Immuneel and Arogya Finance Launch India’s First Zero Cost EMI Program of up to ₹25 Lakhs for Qartemi® (Varnimcabtagene autoleucel) CAR-T Cell Therapy
A first-of-its-kind patient access initiative to help eligible patients receive timely CAR-T cell therapy without the burden of arranging the entire treatment cost […]
